Literature DB >> 12888279

Synthesis, structural characterization and in vitro cytotoxicity of organotin(IV) derivatives of heterocyclic thioamides, 2-mercaptobenzothiazole, 5-chloro-2-mercaptobenzothiazole, 3-methyl-2-mercaptobenzothiazole and 2-mercaptonicotinic acid.

Marianna N Xanthopoulou1, Sotiris K Hadjikakou, Nick Hadjiliadis, Markus Schürmann, Klaus Jurkschat, Adonis Michaelides, Stavroula Skoulika, Thomas Bakas, Jayne Binolis, Spyros Karkabounas, Konstantinos Charalabopoulos.   

Abstract

Five new organotin(IV) molecules with the heterocyclic thioamides; 2-mercaptobenzothiazole (Hmbzt), 5-chloro-2-mercaptobenzothiazole (Hcmbzt), 3-methyl-2-mercaptobenzothiazole (mmbzt) and 2-mercaptonicotinic acid (H(2)mna) of formulae [(n-C(4)H(9))(2)Sn(mbzt)(2)] (1), [(C(6)H(5))(2)Sn(mbzt)(2)] (2), [(CH(3))(2)Sn(cmbzt)(2)].1.7(H(2)O)] (3), [(n-C(4)H(9))(2)SnCl(2)(mmbzt)(2).(CH(2)Cl(2))] (4) and [[(C(6)H(5))(3)Sn](2)(mna).[(CH(3))(2)CO]] (5) have been synthesized and characterized by elemental analysis, 1H-, 13C-NMR, FT-IR and Mössbauer spectroscopic techniques. Crystal structures of molecules 1, 3 and 5 have been determined by X-ray diffraction at 173(1) K (1 and 5) and 293(2) K (3). Compound 1 C(22)H(26)N(2)S(4)Sn, is monoclinic, space group C2/c, a=44.018(2), b=8.8864(5), c=12.8633(7) A, beta=104.195(5) degrees, Z=8. Compound 3 is also monoclinic, space group P2(1)/c and a=17.128(2) A, b=17.919(2) A, c=7.3580(10) A, beta=98.290(10) degrees, Z=4. In both molecules 1 and 3, two carbon atoms from aryl groups, two sulfur and two nitrogen atoms from thione ligands form a distorted octahedral geometry around tin(IV) with trans-C(2), cis-N(2), cis-S(2) configurations. Compound 5 C(45)H(39)NO(3)SSn(2) is monoclinic, space group P2(1)/n, a=9.1148(2) A, b=29.2819(6), c=15.5556(4) A, beta=106.2851(9) degrees, Z=4. Complex 5 contains two [(C(6)H(5))(3)Sn(IV)] moieties linked by a double deprotonated 2-mercaptonicotinic acid (H(2)mna). Both tin(IV) ions are five coordinated. This complex is the an example of a pentacoordinated Ph(3)SnXY system with an axial-equatorial arrangement of the phenyl groups at Sn(1) atom. Compounds 1, 3 and 5 were tested for in vitro cytotoxicity against the cancer cell line of sarcoma cells (mesenchymal tissue) from the Wistar rat, polycyclic aromatic hydrocarbons (benzo[a]pyrene) carcinogenesis. Compound 5 exhibits strong cytotoxic activity, while complexes 1 and 3 show less cytotoxic activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12888279     DOI: 10.1016/s0162-0134(03)00178-8

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  10 in total

1.  Amino acetate functionalized Schiff base organotin(IV) complexes as anticancer drugs: synthesis, structural characterization, and in vitro cytotoxicity studies.

Authors:  Tushar S Basu Baul; Smita Basu; Dick de Vos; Anthony Linden
Journal:  Invest New Drugs       Date:  2008-10-22       Impact factor: 3.850

2.  Synthesis, characterization, and binding properties towards CT-DNA and lipoxygenase of mixed-ligand silver(I) complexes with 2-mercaptothiazole and its derivatives and triphenylphosphine.

Authors:  L Kyros; C N Banti; N Kourkoumelis; M Kubicki; I Sainis; S K Hadjikakou
Journal:  J Biol Inorg Chem       Date:  2014-01-21       Impact factor: 3.358

3.  Structural properties, cytotoxicity, and anti-inflammatory activity of silver(I) complexes with tris(p-tolyl)phosphine and 5-chloro-2-mercaptobenzothiazole.

Authors:  L Kyros; N Kourkoumelis; M Kubicki; L Male; M B Hursthouse; I I Verginadis; E Gouma; S Karkabounas; K Charalabopoulos; S K Hadjikakou
Journal:  Bioinorg Chem Appl       Date:  2010-03-29       Impact factor: 7.778

4.  Crystal structure and antitumor activity of the novel zwitterionic complex of tri-n-butyltin(IV) with 2-thiobarbituric acid.

Authors:  Vasilios I Balas; Sotiris K Hadjikakou; Nick Hadjiliadis; Nikolaos Kourkoumelis; Mark E Light; Mike Hursthouse; Apostolos K Metsios; Spyros Karkabounas
Journal:  Bioinorg Chem Appl       Date:  2008       Impact factor: 7.778

Review 5.  Antiviral Activity of Metal-Containing Polymers-Organotin and Cisplatin-Like Polymers.

Authors:  Michael R Roner; Charles E Carraher; Kimberly Shahi; Girish Barot
Journal:  Materials (Basel)       Date:  2011-05-27       Impact factor: 3.623

6.  Nanoparticles of novel organotin(IV) complexes bearing phosphoric triamide ligands.

Authors:  Zahra Shariatinia; Ebadullah Asadi; Vahid Tavasolinasab; Khodayar Gholivand
Journal:  Beilstein J Nanotechnol       Date:  2013-02-12       Impact factor: 3.649

7.  Synthesis, characterization, and biological studies of organotin(IV) derivatives with o- or p-hydroxybenzoic acids.

Authors:  Mohamed A Abdellah; Sotiris K Hadjikakou; Nick Hadjiliadis; Maciej Kubicki; Thomas Bakas; Nikolaos Kourkoumelis; Yannis V Simos; Spyros Karkabounas; Mirela M Barsan; Ian S Butler
Journal:  Bioinorg Chem Appl       Date:  2009-04-15       Impact factor: 7.778

8.  Monobenzyltin Complex C1 Induces Apoptosis in MCF-7 Breast Cancer Cells through the Intrinsic Signaling Pathway and through the Targeting of MCF-7-Derived Breast Cancer Stem Cells via the Wnt/β-Catenin Signaling Pathway.

Authors:  Somayeh Fani; Firouzeh Dehghan; Hamed Karimian; Kong Mun Lo; Siyamak Ebrahimi Nigjeh; Yeap Swee Keong; Rahman Soori; Kit May Chow; Behnam Kamalidehghan; Hapipah Mohd Ali; Najihah Mohd Hashim
Journal:  PLoS One       Date:  2016-08-16       Impact factor: 3.240

9.  Synthesis, structural characterization, and anticancer activity of a monobenzyltin compound against MCF-7 breast cancer cells.

Authors:  Somayeh Fani; Behnam Kamalidehghan; Kong Mun Lo; Najihah Mohd Hashim; Kit May Chow; Fatemeh Ahmadipour
Journal:  Drug Des Devel Ther       Date:  2015-11-23       Impact factor: 4.162

10.  Poly Organotin Acetates against DNA with Possible Implementation on Human Breast Cancer.

Authors:  George K Latsis; Christina N Banti; Nikolaos Kourkoumelis; Constantina Papatriantafyllopoulou; Nikos Panagiotou; Anastasios Tasiopoulos; Alexios Douvalis; Angelos G Kalampounias; Thomas Bakas; Sotiris K Hadjikakou
Journal:  Int J Mol Sci       Date:  2018-07-14       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.